CIC
AGN

Chilton Investment Company’s Allergan plc AGN Stock Holding History

Chilton Investment Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-154,364
Closed -$31.6M – 139
2017
Q3 		$31.6M Sell
154,364
-1,801
-1% -$419K 1.22% 33
2017
Q2 		$38M Sell
156,165
-15,828
-9% -$3.72M 1.46% 26
2017
Q1 		$41.1M Sell
171,993
-107,761
-39% -$25.1M 1.6% 25
2016
Q4 		$58.8M Sell
279,754
-178,742
-39% -$37M 2.38% 15
2016
Q3 		$106M Buy
458,496
+42,240
+10% +$10.3M 4.12% 6
2016
Q2 		$96.2M Sell
416,256
-15,127
-4% -$3.49M 3.41% 9
2016
Q1 		$116M Buy
431,383
+22,673
+6% +$6.49M 4.25% 8
2015
Q4 		$128M Sell
408,710
-8,951
-2% -$2.66M 4.49% 5
2015
Q3 		$114M Buy
417,661
+22,661
+6% +$6.96M 4.04% 5
2015
Q2 		$120M Buy
395,000
+43,331
+12% +$12.9M 4.39% 3
2015
Q1 		$105M Buy
351,669
+6,763
+2% +$1.93M 3.72% 3
2014
Q4 		$88.8M Buy
344,906
+68,410
+25% +$17.1M 3.09% 5
2014
Q3 		$66.7M Buy
+276,496
New +$61.9M 2.24% 13

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Chilton Investment Company's AGN Position: Q4 2017 in Review

Chilton Investment Company sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 154,364 shares — an estimated $31.6M sold.

Chilton Investment Company first reported a position in AGN in Q3 2014 and held it in 13 quarters. The position peaked at $128M in Q4 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Chilton Investment Company reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Chilton Investment Company sold 154,364 Allergan plc shares in Q4 2017, an estimated $31.6M.
  • Chilton Investment Company first reported a position in Allergan plc in Q3 2014 and held it in 13 quarters.
  • Chilton Investment Company's Allergan plc position peaked at $128M in Q4 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Chilton Investment Company's 13F filing for Q4 2017, filed 7 Feb 2018.